{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:34:12Z","timestamp":1779399252080,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10549-023-06905-3","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T06:02:41Z","timestamp":1680847361000},"page":"215-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-2544","authenticated-orcid":false,"given":"Lindsey R.","family":"Fauveau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuoc N.","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy B.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufaddal K.","family":"Mamawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Obaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Waddimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"key":"6905_CR1","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1245\/s10434-016-5596-2","volume":"23","author":"LJ Grimm","year":"2016","unstructured":"Grimm LJ, Shelley Hwang E (2016) Active surveillance for DCIS: The importance of selection criteria and monitoring. Ann Surg Oncol 23:4134\u20134136. https:\/\/doi.org\/10.1245\/s10434-016-5596-2","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"6905_CR2","doi-asserted-by":"publisher","first-page":"djv263","DOI":"10.1093\/jnci\/djv263.PMID:26424776;PMCID:PMC4707192","volume":"107","author":"M Worni","year":"2015","unstructured":"Worni M, Akushevich I, Greenup R, Sarma D, Ryser MD, Myers ER, Hwang ES (2015) Trends in treatment patterns and outcomes for ductal carcinoma in situ. J Natl Cancer Inst 107(12):djv263. https:\/\/doi.org\/10.1093\/jnci\/djv263.PMID:26424776;PMCID:PMC4707192","journal-title":"J Natl Cancer Inst"},{"issue":"41","key":"6905_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","volume":"2010","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske K (2010) Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010(41):139\u2013141. https:\/\/doi.org\/10.1093\/jncimonographs\/lgq027","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"20","key":"6905_CR4","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","volume":"94","author":"V Ernster","year":"2002","unstructured":"Ernster V, Ballard-Barbash R, Barlow W et al (2002) Detection of DCIS in women undergoing screening mammography. J Natl Cancer Inst 94(20):1546\u20131554","journal-title":"J Natl Cancer Inst"},{"issue":"33","key":"6905_CR5","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","volume":"33","author":"LJ Solin","year":"2015","unstructured":"Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, Baehner FL, Ingle JN, Perez EA, Recht A, Sparano JA, Davidson NE (2015) Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol. 33(33):3938\u201344. https:\/\/doi.org\/10.1200\/JCO.2015.60.8588","journal-title":"J Clin Oncol."},{"issue":"6","key":"6905_CR6","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO;2-G","volume":"75","author":"ER Fisher","year":"1995","unstructured":"Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E (1995) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer 75(6):1310\u20131319","journal-title":"Cancer"},{"issue":"4","key":"6905_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/SLA.0000000000001454","volume":"262","author":"KJ Van Zee","year":"2015","unstructured":"Van Zee KJ, Subhedar P, Olcese C, Patil S, Morrow M (2015) Relationship between margin width and recurrence of ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery for 30 years. Ann Surg 262(4):623\u2013631. https:\/\/doi.org\/10.1097\/SLA.0000000000001454","journal-title":"Ann Surg"},{"key":"6905_CR8","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"N Bijker","year":"2006","unstructured":"Bijker N, Meijnen P, Peterse JL et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853\u2014A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381\u20133387","journal-title":"J Clin Oncol"},{"key":"6905_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Sestak I, Pinder SE et al (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK\/ANZ DCIS trial. Lancet Oncol 12:21\u201329","journal-title":"Lancet Oncol"},{"key":"6905_CR10","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","volume":"31","author":"M Donker","year":"2013","unstructured":"Donker M, Litiere S, Werutsky G et al (2013) Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31:4054\u20134059","journal-title":"J Clin Oncol"},{"key":"6905_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-050715-104920","volume":"68","author":"AV Barrio","year":"2017","unstructured":"Barrio AV, Van Zee KJ (2017) Controversies in the Treatment of Ductal Carcinoma in Situ. Annu Rev Med 68:197\u2013211. https:\/\/doi.org\/10.1146\/annurev-med-050715-104920","journal-title":"Annu Rev Med"},{"issue":"1","key":"6905_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1309\/WH9LA543NR76Y29J","volume":"128","author":"ER Fisher","year":"2007","unstructured":"Fisher ER, Land SR, Saad RS et al (2007) Pathologic variables predictive of breast events in patients with ductal carcinoma in situ. Am J Clin Pathol 128(1):86\u201391","journal-title":"Am J Clin Pathol"},{"key":"6905_CR13","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V","volume":"77","author":"MJ Silverstein","year":"1996","unstructured":"Silverstein MJ, Lagios MD, Craig PH et al (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267\u20132274","journal-title":"Cancer"},{"key":"6905_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jso.23990","volume":"112","author":"SE Abe","year":"2015","unstructured":"Abe SE, Hill JS, Han Y, Walsh K, Symanowski JT, Hadzikadic-Gusic L, Flippo-Morton T, Sarantou T, Forster M, White RL Jr (2015) Margin re-excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model. J Surg Oncol 112:443\u2013448. https:\/\/doi.org\/10.1002\/jso.23990","journal-title":"J Surg Oncol"},{"issue":"10","key":"6905_CR15","doi-asserted-by":"publisher","first-page":"e203025","DOI":"10.1001\/jamasurg.2020.3025","volume":"155","author":"ML Marinovich","year":"2020","unstructured":"Marinovich ML, Noguchi N, Morrow M, Houssami N (2020) Changes in reoperation after publication of consensus guidelines on margins for breast-conserving surgery: a systematic review and meta-analysis. JAMA Surg. 155(10):e203025. https:\/\/doi.org\/10.1001\/jamasurg.2020.3025","journal-title":"JAMA Surg."},{"issue":"5","key":"6905_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.prro.2016.06.011","volume":"6","author":"M Morrow","year":"2016","unstructured":"Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR et al (2016) Society of surgical oncology-american society for radiation oncology-american society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol. 6(5):287\u2013295. https:\/\/doi.org\/10.1016\/j.prro.2016.06.011","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"6905_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.mayocp.2017.11.023","volume":"93","author":"BL Murphy","year":"2018","unstructured":"Murphy BL, Boughey JC, Keeney MG, Glasgow AE, Racz JM, Keeney GL, Habermann EB (2018) Factors associated with positive margins in women undergoing breast conservation surgery. Mayo Clin Proc 93(4):429\u2013435. https:\/\/doi.org\/10.1016\/j.mayocp.2017.11.023. (Epub 2018 Feb 10 PMID: 29439832)","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"6905_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/jamasurg.2016.4751","volume":"152","author":"L Langhans","year":"2017","unstructured":"Langhans L, Jensen M, Talman MM, Vejborg I, Kroman N, Tvedskov TF (2017) Reoperation rates in ductal carcinoma in situ vs invasive breast cancer after wire-guided breast-conserving surgery. JAMA Surg 152(4):378\u2013384. https:\/\/doi.org\/10.1001\/jamasurg.2016.4751","journal-title":"JAMA Surg"},{"issue":"2","key":"6905_CR19","doi-asserted-by":"publisher","first-page":"995","DOI":"10.4103\/0973-1482.172135","volume":"12","author":"RA Hassan","year":"2016","unstructured":"Hassan RA, Maesaka JY, Ricci MD, Soares JM, D\u00f3ria MT, Baracat EC, Filassi JR (2016) Predictive factors for positive surgical margins in the treatment of breast ductal carcinoma in situ. J Can Res Ther. 12(2):995\u20138. https:\/\/doi.org\/10.4103\/0973-1482.172135. (PMID: 27461687)","journal-title":"J Can Res Ther."},{"issue":"3","key":"6905_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1245\/s10434-015-4916-2","volume":"23","author":"AL Merrill","year":"2016","unstructured":"Merrill AL, Coopey SB, Tang R, McEvoy MP, Specht MC, Hughes KS, Gadd MA, Smith BL (2016) Implications of new lumpectomy margin guidelines for breast-conserving surgery: changes in reexcision rates and predicted rates of residual tumor. Ann Surg Oncol 23(3):729","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"6905_CR21","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.7150\/jca.20871","volume":"8","author":"HM Kuerer","year":"2017","unstructured":"Kuerer HM, Smith BD, Chavez-MacGregor M et al (2017) DCIS margins and breast conservation: MD Anderson cancer center multidisciplinary practice guidelines and outcomes. J Cancer. 8(14):2653\u20132662. https:\/\/doi.org\/10.7150\/jca.20871","journal-title":"J Cancer."},{"issue":"1","key":"6905_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejso.2014.08.474","volume":"41","author":"MW Barentsz","year":"2015","unstructured":"Barentsz MW, Postma EL, van Dalen T, van den Bosch MA, Miao H, Gobardhan PD, van den Hout LE, Pijnappel RM, Witkamp AJ, van Diest PJ, van Hillegersberg R, Verkooijen HM (2015) Prediction of positive resection margins in patients with non-palpable breast cancer. Eur J Surg Oncol 41(1):106\u2013112. https:\/\/doi.org\/10.1016\/j.ejso.2014.08.474. (Epub 2014 Sep 2 PMID: 25228054)","journal-title":"Eur J Surg Oncol"},{"key":"6905_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3322\/caac.21393","volume":"67","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ, Hortobagyi GN (2017) Breast cancer major changes in the american joint committee on cancer eighth edition cancer staging manual. Cancer J Clin 67:290\u2013303. https:\/\/doi.org\/10.3322\/caac.21393","journal-title":"Cancer J Clin"},{"key":"6905_CR24","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJM199905133401902","volume":"340","author":"MJ Silverstein","year":"1999","unstructured":"Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S et al (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455\u20131461","journal-title":"N Engl J Med"},{"issue":"5","key":"6905_CR25","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ajpath.2018.07.031","volume":"189","author":"S Sanati","year":"2019","unstructured":"Sanati S (2019) Morphologic and molecular features of breast ductal carcinoma in situ. Am J Pathol 189(5):946\u2013955. https:\/\/doi.org\/10.1016\/j.ajpath.2018.07.031","journal-title":"Am J Pathol"},{"issue":"9","key":"6905_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/jnci\/djq101","volume":"102","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD (2010) Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 102(9):627\u2013637","journal-title":"J Natl Cancer Inst"},{"key":"6905_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.7150\/jca.2.232","volume":"2","author":"SA Lari","year":"2011","unstructured":"Lari SA, Kuerer HM (2011) Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review. J Cancer 2:232\u2013261. https:\/\/doi.org\/10.7150\/jca.2.232","journal-title":"J Cancer"},{"issue":"3","key":"6905_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/jso.24047","volume":"113","author":"CM O'Kelly Priddy","year":"2016","unstructured":"O\u2019Kelly Priddy CM, Forte VA, Lang JE (2016) The importance of surgical margins in breast cancer. J Surg Oncol 113(3):256\u201363. https:\/\/doi.org\/10.1002\/jso.24047","journal-title":"J Surg Oncol"},{"issue":"6","key":"6905_CR29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.21037\/gs.2018.11.03","volume":"7","author":"MP McEvoy","year":"2018","unstructured":"McEvoy MP, Landercasper J, Naik HR, Feldman S (2018) Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic. Gland Surg 7(6):536\u2013553. https:\/\/doi.org\/10.21037\/gs.2018.11.03","journal-title":"Gland Surg"},{"key":"6905_CR30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10549-020-05816-x","volume":"183","author":"EJ Groen","year":"2020","unstructured":"Groen EJ, Hudecek J, Mulder L et al (2020) Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study. Breast Cancer Res Treat 183:759\u2013770","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06905-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-06905-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06905-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T17:52:32Z","timestamp":1683827552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-06905-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6905"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-06905-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study involving human participants was in accordance with the ethical standards of the institution and\/or national research committee and in line with the principles of the Declaration of Helsinki. Approval was granted by the review boards of Baylor Scott and White Research Institute.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study used only unidentifiable patient information, and no informed consent was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}